Stocks Health care BETRF

OTC · Health care

BetterLife Pharma Inc. (BETRF)

It posted a net loss of $6.7M. At October 31, 2018 it held $406.9K in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on June 1, 2026.

Watch BETRF in 60 seconds

What BetterLife Pharma Inc. does

BetterLife Pharma Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BETRF.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What BetterLife Pharma Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 22, 2026
   Passive stake (5% or more) SCHEDULE 13G
2. September 15, 2026
   Foreign issuer update 6-K
3. September 11, 2026
   Foreign issuer update 6-K
4. August 24, 2026
   Foreign issuer update 6-K
5. August 5, 2026
   Foreign issuer update 6-K
6. June 26, 2026
   Foreign issuer update 6-K
7. June 25, 2026
   Foreign issuer update 6-K
8. June 1, 2026
   Annual report (foreign issuer) 20-F · period to January 31, 2026
9. April 13, 2026
   Foreign issuer update 6-K
10. September 29, 2025
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 6, the latest on March 10, 2015. Insider transactions on SEC

Who owns BETRF

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BETRF

What does BetterLife Pharma Inc. do?

BetterLife Pharma Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BETRF.

Is BetterLife Pharma Inc. profitable?

No. Over the twelve months to October 31, 2018 it reported a net loss of $6.7M.

When did BetterLife Pharma Inc. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on June 1, 2026. It covers the period to January 31, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 22, 2026.

Similar companies

Compare BETRF with

Compare BETRF with any company

Follow BETRF

Get an email when BetterLife Pharma Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BETRF: get an email when it files

Where the numbers come from

Financial figures are the values BetterLife Pharma Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.